About us
Our Company
Moonlight Therapeutics is focused on developing therapies for food allergy.
Moonlight's founders are experts in drug delivery, specifically in designing systems to get across the body's barriers so drugs can be delivered effectively to their intended target. Our proprietary skin stamp delivers antigen to the skin's immune cells to protect patients from deadly anaphylactic reactions.
Our Backing
Strong technology backed by public and private funding
Moonlight Therapeutics has received multiple grants from the National Institutes of Health to develop its allergen immunotherapy platform and its first treatment for peanut allergy, MOON101.
We are supported by public and private funds to evaluate MOON101 in our first clinical trial with peanut allergic adults and children.
Join us in stamping out food allergy.
